ZBIO

ProShares UltraPro Short NASDAQ Biotechnology
ZBIO

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

ZBIO was delisted on the 27th of March, 2020.

Back to rankings

4 hedge funds and large institutions have $1.2M invested in ProShares UltraPro Short NASDAQ Biotechnology in 2015 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $
Holders
4
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$630K
Puts
$18K
Net Calls
Net Calls Change

Top Buyers

1
+$384K
2
+$328K
3
+$28K

Top Sellers

1
-$1.08M
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$521K
2
$394K
3
$258K
4
$28K
5
–